| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
51,065 |
40,374 |
$14.45M |
| 87536 |
|
17,367 |
16,205 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38,567 |
25,504 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,347 |
14,959 |
$975.93 |
| 96150 |
|
784 |
476 |
$945.00 |
| 80061 |
Lipid panel |
11,394 |
10,300 |
$596.14 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
909 |
560 |
$545.20 |
| 80053 |
Comprehensive metabolic panel |
23,750 |
21,037 |
$487.81 |
| 0012A |
|
252 |
237 |
$280.47 |
| 90739 |
|
339 |
336 |
$270.11 |
| 0011A |
|
293 |
241 |
$200.37 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
118 |
64 |
$186.62 |
| 99215 |
Prolong outpt/office vis |
3,124 |
2,802 |
$170.97 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
218 |
191 |
$100.00 |
| 86777 |
|
1,215 |
1,090 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
28,780 |
23,980 |
$0.00 |
| 86635 |
|
2,890 |
2,538 |
$0.00 |
| 82043 |
|
5,254 |
4,836 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,291 |
17,261 |
$0.00 |
| 82670 |
|
807 |
774 |
$0.00 |
| 90732 |
|
982 |
921 |
$0.00 |
| 85027 |
|
4,004 |
3,485 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
8,313 |
7,615 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,237 |
4,781 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
345 |
330 |
$0.00 |
| 86704 |
|
1,697 |
1,531 |
$0.00 |
| 81001 |
|
6,841 |
6,224 |
$0.00 |
| 84270 |
|
1,296 |
1,215 |
$0.00 |
| 87900 |
|
381 |
349 |
$0.00 |
| 86762 |
|
1,885 |
1,654 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,259 |
1,747 |
$0.00 |
| 86593 |
|
4,783 |
4,177 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,357 |
6,905 |
$0.00 |
| 82955 |
|
1,158 |
1,063 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
237 |
226 |
$0.00 |
| 86780 |
|
4,675 |
3,936 |
$0.00 |
| 0134A |
|
455 |
429 |
$0.00 |
| 87486 |
|
83 |
74 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
535 |
508 |
$0.00 |
| 1126F |
|
2,154 |
2,077 |
$0.00 |
| 86803 |
|
7,899 |
7,077 |
$0.00 |
| 86592 |
|
11,871 |
10,566 |
$0.00 |
| 83615 |
|
501 |
389 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
918 |
639 |
$0.00 |
| 3080F |
|
456 |
448 |
$0.00 |
| 3074F |
|
1,536 |
1,482 |
$0.00 |
| 87340 |
|
1,764 |
1,594 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
320 |
312 |
$0.00 |
| 90686 |
|
2,955 |
2,877 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
9,349 |
8,652 |
$0.00 |
| 86701 |
|
653 |
590 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
11,230 |
9,058 |
$0.00 |
| 90674 |
|
672 |
609 |
$0.00 |
| 86706 |
|
2,259 |
2,040 |
$0.00 |
| 80320 |
|
115 |
84 |
$0.00 |
| 90677 |
|
287 |
276 |
$0.00 |
| 86702 |
|
693 |
617 |
$0.00 |
| 3079F |
|
1,179 |
1,143 |
$0.00 |
| 87906 |
|
575 |
514 |
$0.00 |
| 90480 |
|
512 |
438 |
$0.00 |
| 82607 |
|
41 |
40 |
$0.00 |
| 90619 |
|
170 |
170 |
$0.00 |
| 82728 |
|
37 |
36 |
$0.00 |
| 84153 |
|
185 |
176 |
$0.00 |
| 3075F |
|
780 |
762 |
$0.00 |
| 1125F |
|
255 |
251 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
29 |
29 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
177 |
155 |
$0.00 |
| 3048F |
|
12 |
12 |
$0.00 |
| 90656 |
|
385 |
231 |
$0.00 |
| D0230 |
Intraoral - periapical each additional radiographic image |
26 |
24 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
86 |
82 |
$0.00 |
| D0140 |
Limited oral evaluation - problem focused |
13 |
12 |
$0.00 |
| 87581 |
|
82 |
73 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
157 |
147 |
$0.00 |
| 82746 |
|
26 |
26 |
$0.00 |
| 96156 |
|
27 |
18 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
95 |
91 |
$0.00 |
| 99205 |
Prolong outpt/office vis |
42 |
37 |
$0.00 |
| 0064A |
|
268 |
233 |
$0.00 |
| D0120 |
Periodic oral evaluation - established patient |
24 |
24 |
$0.00 |
| 3044F |
|
28 |
28 |
$0.00 |
| 83550 |
|
12 |
12 |
$0.00 |
| D7140 |
Extraction, erupted tooth or exposed root |
19 |
12 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,848 |
2,666 |
$0.00 |
| 3078F |
|
1,186 |
1,145 |
$0.00 |
| 82570 |
|
6,200 |
5,563 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,911 |
1,764 |
$0.00 |
| 84403 |
|
1,739 |
1,589 |
$0.00 |
| 86480 |
|
5,797 |
5,244 |
$0.00 |
| 88112 |
|
1,756 |
1,656 |
$0.00 |
| 84156 |
|
2,713 |
2,379 |
$0.00 |
| 86787 |
|
1,803 |
1,579 |
$0.00 |
| 85007 |
|
4,001 |
3,483 |
$0.00 |
| 87901 |
|
542 |
498 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
11,188 |
9,057 |
$0.00 |
| 86360 |
|
21,245 |
18,957 |
$0.00 |
| 86644 |
|
1,260 |
1,129 |
$0.00 |
| 86359 |
|
21,243 |
18,956 |
$0.00 |
| 1160F |
|
2,539 |
2,329 |
$0.00 |
| 81025 |
|
55 |
52 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,055 |
898 |
$0.00 |
| 81381 |
|
779 |
645 |
$0.00 |
| 86708 |
|
1,824 |
1,652 |
$0.00 |
| 90670 |
|
454 |
405 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,403 |
3,798 |
$0.00 |
| 86645 |
|
1,263 |
1,128 |
$0.00 |
| 90750 |
|
1,037 |
1,031 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,239 |
1,013 |
$0.00 |
| 90715 |
|
569 |
533 |
$0.00 |
| 86765 |
|
1,896 |
1,667 |
$0.00 |
| 90707 |
|
207 |
202 |
$0.00 |
| 86735 |
|
1,803 |
1,621 |
$0.00 |
| 91322 |
|
394 |
381 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
2,090 |
836 |
$0.00 |
| 90746 |
|
415 |
361 |
$0.00 |
| 82652 |
|
362 |
227 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
27 |
14 |
$0.00 |
| 1159F |
|
2,941 |
2,634 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
39 |
24 |
$0.00 |
| 3077F |
|
522 |
506 |
$0.00 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
57 |
36 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
148 |
136 |
$0.00 |
| D0220 |
Intraoral - periapical first radiographic image |
103 |
100 |
$0.00 |
| 83540 |
|
12 |
12 |
$0.00 |
| 90649 |
|
666 |
649 |
$0.00 |
| D1120 |
Prophylaxis - child |
40 |
40 |
$0.00 |
| 84146 |
|
12 |
12 |
$0.00 |
| 0013A |
|
42 |
41 |
$0.00 |
| 90734 |
|
115 |
112 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
349 |
287 |
$0.00 |
| 85610 |
|
121 |
102 |
$0.00 |
| 90611 |
|
342 |
335 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
33 |
30 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
34 |
31 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
35 |
30 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
83 |
74 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
29 |
29 |
$0.00 |
| 86331 |
|
96 |
73 |
$0.00 |
| 84439 |
|
12 |
12 |
$0.00 |